Topical pimecrolimus in the treatment of genital lichen planus: A prospective case series

British Journal of Dermatology

Volumn 153, Issue 2, 2005, Pages 390-394

  Lonsdale Eccles, A A ^a   Velangi, S ^a  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

Genital; Lichen planus; Pimecrolimus; Tacrolimus; Vulva

Indexed keywords

PIMECROLIMUS; TACROLIMUS;

ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CONTROLLED STUDY; CREAM; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GYNECOLOGIC DISEASE; HERPES SIMPLEX; HUMAN; LICHEN PLANUS; PAIN; PRIORITY JOURNAL; PRURITUS; SKIN ATROPHY; SKIN IRRITATION;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; DERMATOLOGIC AGENTS; FEMALE; GENITAL DISEASES, FEMALE; GENITALIA, FEMALE; HUMANS; LICHEN PLANUS; MIDDLE AGED; PROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 24144433476     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06544.x     Document Type: Article

References (13)

1. Vente C, Reich K, Rupprecht R et al. Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol 1999; 140:338-42.
2. Lotery HE, Galask RP. Erosive lichen planus of the vulva and vagina. Obstet Gynecol 2003; 101:1121-5.
3. Kirtschig G, van der Meulen AJ, Ion Lipan JW et al. Successful treatment of erosive vulvovaginal lichen planus with topical tacrolimus. Br J Dermatol 2002; 147:625-6.
4. Watsky KL. Erosive perianal lichen planus responsive to tacrolimus. Int J Dermatol 2003; 42:217-18.
5. Jensen JT, Bird M, Leclair CM. Patient satisfaction after the treatment of vulvovaginal erosive lichen planus with topical clobetasol and tacrolimus: a survey study. Am J Obstet Gynecol 2004; 190:1759-63; discussion 1763-5.
6. Byrd JA, Davis MD, Rogers RS 3rd. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. Arch Dermatol 2004; 140:715-20.
7. Panhans-Gross A, Novak N, Kraft S et al. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol 2001; 107:345-52.
8. Meingassner JG, Fahrngruber H, Bavandi A. Pimecrolimus inhibits the elicitation phase but does not suppress the sensitization phase in murine contact hypersensitivity, in contrast to tacrolimus and cyclosporine A. J Invest Dermatol 2003; 121:77-80.
9. Meingassner JG, Kowalsky E, Schwendinger H et al. Pimecrolimus does not affect Langerhans cells in murine epidermis. Br J Dermatol 2003; 149:853-7.
10. Billich A, Aschauer H, Aszodi A et al. Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm 2004; 269:29-35.
11. Gupta AK, Chow M. Pimecrolimus: a review. J Eur Acad Dermatol Venereol 2003; 17:493-503.
12. Dissemond J, Schroter S, Franckson T et al. Pimecrolimus in an adhesive ointment as a new treatment option for oral lichen planus. Br J Dermatol 2004; 150:782-4.
13. Esquivel-Pedraza L, Fernandez-Cuevas L, Ortiz-Pedroza G et al. Treatment of oral lichen planus with topical pimecrolimus 1% cream. Br J Dermatol 2004; 150:771-3.